首页 > 最新文献

Journal of Cancer Policy最新文献

英文 中文
INSTITUTIONAL PRACTICES FOR CANCER: COMPARISON OF SOCIAL AND HEALTH CARE ALONG DISEASE TRAJECTORY IN FIVE COUNTRIES WITH HIGH SURVIVAL RATES. 癌症的机构做法:五个高存活率国家沿疾病轨迹的社会和卫生保健比较。
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-21 DOI: 10.1016/j.jcpo.2026.100733
Carla Calderón-Figueroa, Alondra Castillo-Delgado, Lorena Rodriguez-Osiac, Enrique A Castellón, Klaus Puschel, Óscar Arteaga, Alejandra Fuentes-García

Aim: This article analyses the institutional practices that shape socio-health care for cancer along the disease trajectory-from screening to survivorship-in five countries with the highest cancer survival rates: Australia, Belgium, Canada, Costa Rica, and Japan.

Methods: Drawing on social practice theory, the study applies a critical documentary analysis of 115 institutional and scientific sources, including national cancer plans, legislation, and clinical guidelines, to examine how material elements, practical knowledge, and shared meanings are articulated in policy and practice.

Results: Findings reveal consistent patterns across the five high-survival countries, including the strong institutionalisation of screening programmes, continuous strengthening of diagnostic infrastructure, and establishment of interdisciplinary teams. However, significant challenges persist in addressing territorial inequalities, ensuring equitable access, and protecting patients from out-of-pocket costs associated with innovative therapies. Japan is distinguished by its population-based endoscopic screening for gastric cancer, while Australia and Canada lead in culturally adapted, community-based approaches. Costa Rica shows partial implementation through regional pilots, and Belgium displays high diagnostic and therapeutic integration with European networks. Psychosocial, financial, and legal support emerge as indispensable dimensions for achieving equitable and comprehensive cancer care. Non-governmental organisations and community networks play a central role in providing counselling, subsidies, and reintegration support, although their reach varies across contexts. Overall, the study underscores that biomedical innovation alone is insufficient: cancer survival depends on the effective coordination of biomedical, social, cultural, and legal policies within integrated socio-health care systems that prioritise equity and quality of life as key pillars of public cancer policy. In high-performing systems, survivorship is not merely the result of clinical coverage but emerges from an institutional ecosystem that bridges biological recovery and social citizenship.

目的:本文分析了澳大利亚、比利时、加拿大、哥斯达黎加和日本这五个癌症存活率最高的国家,从筛查到生存,沿着疾病轨迹塑造癌症社会卫生保健的制度实践。方法:借鉴社会实践理论,本研究对115个机构和科学来源(包括国家癌症计划、立法和临床指南)进行了批判性的文献分析,以检查物质要素、实践知识和共享意义如何在政策和实践中表达出来。结果:研究结果揭示了五个高存活率国家的一致模式,包括筛查计划的强有力的制度化,诊断基础设施的不断加强,以及跨学科团队的建立。然而,在解决地域不平等、确保公平获取和保护患者免受与创新疗法相关的自付费用方面,仍然存在重大挑战。日本以以人群为基础的胃癌内镜筛查而闻名,而澳大利亚和加拿大在适应文化、以社区为基础的方法方面处于领先地位。哥斯达黎加通过区域试点实现了部分实施,比利时与欧洲网络实现了高度的诊断和治疗一体化。社会心理、经济和法律支持成为实现公平和全面癌症治疗不可或缺的方面。非政府组织和社区网络在提供咨询、补贴和重返社会支持方面发挥着核心作用,尽管它们的覆盖范围因情况而异。总体而言,该研究强调仅靠生物医学创新是不够的:癌症生存取决于综合社会卫生保健系统内生物医学、社会、文化和法律政策的有效协调,该系统优先考虑公平和生活质量,将其作为公共癌症政策的关键支柱。在高绩效的系统中,幸存者不仅仅是临床覆盖的结果,而且来自连接生物恢复和社会公民身份的制度生态系统。
{"title":"INSTITUTIONAL PRACTICES FOR CANCER: COMPARISON OF SOCIAL AND HEALTH CARE ALONG DISEASE TRAJECTORY IN FIVE COUNTRIES WITH HIGH SURVIVAL RATES.","authors":"Carla Calderón-Figueroa, Alondra Castillo-Delgado, Lorena Rodriguez-Osiac, Enrique A Castellón, Klaus Puschel, Óscar Arteaga, Alejandra Fuentes-García","doi":"10.1016/j.jcpo.2026.100733","DOIUrl":"https://doi.org/10.1016/j.jcpo.2026.100733","url":null,"abstract":"<p><strong>Aim: </strong>This article analyses the institutional practices that shape socio-health care for cancer along the disease trajectory-from screening to survivorship-in five countries with the highest cancer survival rates: Australia, Belgium, Canada, Costa Rica, and Japan.</p><p><strong>Methods: </strong>Drawing on social practice theory, the study applies a critical documentary analysis of 115 institutional and scientific sources, including national cancer plans, legislation, and clinical guidelines, to examine how material elements, practical knowledge, and shared meanings are articulated in policy and practice.</p><p><strong>Results: </strong>Findings reveal consistent patterns across the five high-survival countries, including the strong institutionalisation of screening programmes, continuous strengthening of diagnostic infrastructure, and establishment of interdisciplinary teams. However, significant challenges persist in addressing territorial inequalities, ensuring equitable access, and protecting patients from out-of-pocket costs associated with innovative therapies. Japan is distinguished by its population-based endoscopic screening for gastric cancer, while Australia and Canada lead in culturally adapted, community-based approaches. Costa Rica shows partial implementation through regional pilots, and Belgium displays high diagnostic and therapeutic integration with European networks. Psychosocial, financial, and legal support emerge as indispensable dimensions for achieving equitable and comprehensive cancer care. Non-governmental organisations and community networks play a central role in providing counselling, subsidies, and reintegration support, although their reach varies across contexts. Overall, the study underscores that biomedical innovation alone is insufficient: cancer survival depends on the effective coordination of biomedical, social, cultural, and legal policies within integrated socio-health care systems that prioritise equity and quality of life as key pillars of public cancer policy. In high-performing systems, survivorship is not merely the result of clinical coverage but emerges from an institutional ecosystem that bridges biological recovery and social citizenship.</p>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":" ","pages":"100733"},"PeriodicalIF":2.0,"publicationDate":"2026-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147505217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring elements of governance in the development and implementation of national cancer control plans. 探索国家癌症控制计划制定和实施中的治理要素。
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-20 DOI: 10.1016/j.jcpo.2026.100732
Douglas M Puricelli Perin, Mishka Kohli Cira, Xolisile Dlamini, Venus Mushininga, Annet Nakaganda, Suraj Perera, Yannick Romero, Zuzanna Tittenbrun, Kalina Duncan

Governance is an essential component of effective national cancer control plan (NCCP) development and implementation and this study aims to describe how and the extent to which governance is defined and outlined in NCCPs. It utilizes data from a global review of 98 NCCPs in 2023 conducted by 77 experts in cancer control planning using a 95-question form that examines components of NCCP development and implementation. To assess the governance elements represented in NCCPs, we used the Health Policy Triangle (HPT) framework, categorizing questions and developing a score based on its four components: content, context, actors, and mechanisms. Strengths were identified in the adequate involvement of several actors in NCCP development and implementation, such as Ministries of Health, and in appropriate mechanisms for NCCP governance, such as information about who is responsible for plan implementation. However, the inclusion of global cancer control targets and initiatives was often lacking. Overall governance scores were poor, but some variability was observed across WHO regions and country income levels. NCCPs from countries within the WHO Regional Office for Africa and low-income countries presented the highest scores across all four components. The HPT provides a framework to assess NCCPs and may pave the way for the development of further guidance regarding the governance of NCCPs.

治理是有效的国家癌症控制计划(NCCP)制定和实施的重要组成部分,本研究旨在描述国家癌症控制计划如何以及在多大程度上定义和概述治理。它利用了由77位癌症控制规划专家在2023年对98个国家重点控制项目进行的全球审查的数据,使用了95个问题的表格,检查了国家重点控制项目的制定和实施的组成部分。为了评估NCCPs中所代表的治理要素,我们使用了卫生政策三角(HPT)框架,对问题进行分类,并根据其四个组成部分(内容、背景、参与者和机制)进行评分。确定了以下方面的优势:若干行为体(如卫生部)充分参与国家重点控制方案的制定和实施,以及国家重点控制方案治理的适当机制(如关于谁负责计划实施的信息)。然而,往往缺乏将全球癌症控制目标和举措纳入其中。总体治理得分较低,但在世卫组织各区域和国家收入水平之间观察到一些差异。来自世卫组织非洲区域办事处国家和低收入国家的国家结核控制方案在所有四个组成部分中得分最高。HPT提供了一个评估非传染性疾病的框架,并可能为制定有关非传染性疾病治理的进一步指导铺平道路。
{"title":"Exploring elements of governance in the development and implementation of national cancer control plans.","authors":"Douglas M Puricelli Perin, Mishka Kohli Cira, Xolisile Dlamini, Venus Mushininga, Annet Nakaganda, Suraj Perera, Yannick Romero, Zuzanna Tittenbrun, Kalina Duncan","doi":"10.1016/j.jcpo.2026.100732","DOIUrl":"10.1016/j.jcpo.2026.100732","url":null,"abstract":"<p><p>Governance is an essential component of effective national cancer control plan (NCCP) development and implementation and this study aims to describe how and the extent to which governance is defined and outlined in NCCPs. It utilizes data from a global review of 98 NCCPs in 2023 conducted by 77 experts in cancer control planning using a 95-question form that examines components of NCCP development and implementation. To assess the governance elements represented in NCCPs, we used the Health Policy Triangle (HPT) framework, categorizing questions and developing a score based on its four components: content, context, actors, and mechanisms. Strengths were identified in the adequate involvement of several actors in NCCP development and implementation, such as Ministries of Health, and in appropriate mechanisms for NCCP governance, such as information about who is responsible for plan implementation. However, the inclusion of global cancer control targets and initiatives was often lacking. Overall governance scores were poor, but some variability was observed across WHO regions and country income levels. NCCPs from countries within the WHO Regional Office for Africa and low-income countries presented the highest scores across all four components. The HPT provides a framework to assess NCCPs and may pave the way for the development of further guidance regarding the governance of NCCPs.</p>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":" ","pages":"100732"},"PeriodicalIF":2.0,"publicationDate":"2026-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147494627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to "Evidence on vaping e-cigarettes as a risk factor for cancer: A systematic review" [J. Cancer Policy 45C (2025) 100615]. “电子烟作为癌症风险因素的证据:系统综述”的撤回通知[J]。癌症政策45C(2025)[100615]。
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-18 DOI: 10.1016/j.jcpo.2026.100734
Guilherme Guedes de Oliveira, Rebeca Milka Lemos Magalhães Liberato, Amaxsell Thiago Barros de Souza, Ayane Cristine Alves Sarmento, Edilmar de Moura Santos, Kleyton Santos de Medeiros, Irami Araújo Filho
{"title":"Retraction notice to \"Evidence on vaping e-cigarettes as a risk factor for cancer: A systematic review\" [J. Cancer Policy 45C (2025) 100615].","authors":"Guilherme Guedes de Oliveira, Rebeca Milka Lemos Magalhães Liberato, Amaxsell Thiago Barros de Souza, Ayane Cristine Alves Sarmento, Edilmar de Moura Santos, Kleyton Santos de Medeiros, Irami Araújo Filho","doi":"10.1016/j.jcpo.2026.100734","DOIUrl":"https://doi.org/10.1016/j.jcpo.2026.100734","url":null,"abstract":"","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":" ","pages":"100734"},"PeriodicalIF":2.0,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147487804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population-Based Cancer Screening analysis in Northern Portugal Using Process Mining 数据驱动的弹性:优化基于人口的癌症筛查在葡萄牙北部使用过程采矿。
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-05 DOI: 10.1016/j.jcpo.2026.100702
Hugo Monteiro , Mariana Oliveira , Ricardo Martinho , João Reis , Fernando Tavares , Óscar Felgueiras , Carlos Martins

Background

This study focuses on the Colorectal Cancer Screening Program in Northern Portugal, aiming to evaluate the disruption effects on its performance and efficiency.

Methods

We conducted an observational analyses of 271 637 administrative records from 2020 to 2022. Administrative timestamps were converted into a step-by-step dataset of screening activities (an “event log”) and analysed using process mining and comparative performance analysis across time periods and ACeS (primary care administrative clusters).

Results

Consultation‑to‑colonoscopy time lengthened by 53 %, rising from a median 58 days (IQR 29–92) in early 2020 to 89 days (IQR 53–127) in 2021, before improving to 73 days in 2022. Conversely, referral‑to‑consultation time fell from 110 days to 26 days (−76 %), reflecting targeted backlog clearance. Screening volumes declined in 2020 but recovered above baseline levels by 2022. Performance differences across primary care administrative clusters were significant (p < 0.001), with some units outperforming regional median transition times. Early adoption of automated electronic referrals and flexible consultation scheduling may have contributed to improved programme performance during the recovery period following pandemic-related disruptions. Substantial heterogeneity across units was observed for key transitions, indicating uneven disruption and recovery patterns across administrative units.

Conclusion

Process Mining techniques revealed critical vulnerabilities in the screening program during the initial stages of the period in analysis (matching the pandemic). These findings support targeted monitoring and prioritisation of operational improvements to reduce avoidable delays and strengthen continuity of population-based screening.

Policy summary

Policies aimed at strengthening healthcare service continuity and operational capacity benefit from analytical methods like process mining. Key recommendations include standardizing workflows, enhancing coordination between primary care and hospital services, and investing in digital monitoring systems to mitigate disruptions and ensure continuity in cancer screening programs during periods of system stress.
背景:本研究以葡萄牙北部的结直肠癌筛查项目为研究对象,旨在评估干扰对其性能和效率的影响。方法:一项观察性研究分析了2020-2022年的行政记录。该筛查项目于2018年启动,包括一系列活动,从邀请患者到粪便隐血检查和必要时的结肠镜检查。使用流程挖掘技术和比较性能分析,创建事件日志以识别不同时间段和管理区域之间的变化。结果:观察到明显的工作流程中断,特别是在从咨询到结肠镜检查活动的过渡中,延误增加了40%以上,导致瓶颈。一些医疗保健服务通过缩短试剂盒分发和实验室处理活动的延迟,显示出更好的恢复能力。表现差异是显著的,协调良好的地区的过渡时间比协调不佳的地区快30%。事实证明,根据资源限制调整工作流程的能力对于减轻大流行病的影响至关重要。结论:过程挖掘技术揭示了在分析期间(与大流行相匹配)的初始阶段筛选方案中的关键漏洞。有针对性的干预措施,包括采用韧性地区的最佳做法和改进协调工作,对于提高项目的效率和韧性至关重要。策略摘要:提高医疗保健弹性和操作能力的策略受益于流程挖掘等分析方法。主要建议侧重于标准化工作流程,加强初级保健和医院服务之间的协调,以及投资于数字监测系统,以减轻危机期间癌症筛查计划的中断并确保其连续性。
{"title":"Population-Based Cancer Screening analysis in Northern Portugal Using Process Mining","authors":"Hugo Monteiro ,&nbsp;Mariana Oliveira ,&nbsp;Ricardo Martinho ,&nbsp;João Reis ,&nbsp;Fernando Tavares ,&nbsp;Óscar Felgueiras ,&nbsp;Carlos Martins","doi":"10.1016/j.jcpo.2026.100702","DOIUrl":"10.1016/j.jcpo.2026.100702","url":null,"abstract":"<div><h3>Background</h3><div>This study focuses on the Colorectal Cancer Screening Program in Northern Portugal, aiming to evaluate the disruption effects on its performance and efficiency.</div></div><div><h3>Methods</h3><div>We conducted an observational analyses of 271 637 administrative records from 2020 to 2022. Administrative timestamps were converted into a step-by-step dataset of screening activities (an “event log”) and analysed using process mining and comparative performance analysis across time periods and ACeS (primary care administrative clusters).</div></div><div><h3>Results</h3><div>Consultation‑to‑colonoscopy time lengthened by 53 %, rising from a median 58 days (IQR 29–92) in early 2020 to 89 days (IQR 53–127) in 2021, before improving to 73 days in 2022. Conversely, referral‑to‑consultation time fell from 110 days to 26 days (−76 %), reflecting targeted backlog clearance. Screening volumes declined in 2020 but recovered above baseline levels by 2022. Performance differences across primary care administrative clusters were significant (p &lt; 0.001), with some units outperforming regional median transition times. Early adoption of automated electronic referrals and flexible consultation scheduling may have contributed to improved programme performance during the recovery period following pandemic-related disruptions. Substantial heterogeneity across units was observed for key transitions, indicating uneven disruption and recovery patterns across administrative units.</div></div><div><h3>Conclusion</h3><div>Process Mining techniques revealed critical vulnerabilities in the screening program during the initial stages of the period in analysis (matching the pandemic). These findings support targeted monitoring and prioritisation of operational improvements to reduce avoidable delays and strengthen continuity of population-based screening.</div></div><div><h3>Policy summary</h3><div>Policies aimed at strengthening healthcare service continuity and operational capacity benefit from analytical methods like process mining. Key recommendations include standardizing workflows, enhancing coordination between primary care and hospital services, and investing in digital monitoring systems to mitigate disruptions and ensure continuity in cancer screening programs during periods of system stress.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"47 ","pages":"Article 100702"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining the role and competencies of the medical oncologist in diagnostic and therapeutic care pathways: Consensus recommendations from the Italian association of medical oncology (AIOM) 定义医学肿瘤学家在诊断和治疗护理途径中的作用和能力:意大利肿瘤医学协会(AIOM)的共识建议
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-01-12 DOI: 10.1016/j.jcpo.2026.100701
Rossana Berardi , Francesca Rossi , Valentina Tarantino , Michele De Tursi , Angelo Dinota , Giancarlo Di Pinto , Roberto Bianco , Francesco Leonardi , Alessandra Bearz , Alessandra Fabi , Alessandro Pastorino , Franco Nolè , Paolo Alessandroni , Francesco Carrozza , Lucio Buffoni , Tiziana Latiano , Daniele Farci , Massimiliano Spada , Carmelo Bengala , Stefania Kinspergher , Roberto Papa

Background

Diagnostic and Therapeutic Care Pathways (DTCPs) are clinical governance tools aimed at managing the care of specific patient populations through the coordinated application of standardized, evidence-based interventions by multidisciplinary teams. Their primary goal is to ensure equitable, timely, and cost-effective access to high-quality care.

Materials and method

A panel of recognized opinion leaders, endorsed by the Italian Association of Medical Oncology (AIOM), was convened to develop a consensus document defining the role of the medical oncologist within Multidisciplinary Oncology Groups (MOGs) and DTCPs. Employing the RAND/UCLA Appropriateness Method in its “consensus conference” format, the panel evaluated a series of statements derived from a review of the scientific literature and expert-generated Good Practice Points (GPPs). These statements addressed five key areas.
  • 1.
    Skills of the Oncologist in the diagnostic phase
  • 2.
    Follow up
  • 3.
    Palliative care
  • 4.
    Management of the diagnostic and therapeutic care pathway of the oncological patient
  • 5.
    Medical therapy.
To further support each topic, illustrative case studies were presented.

Results

A total of 21 articles met the inclusion criteria, yielding 88 evidence-based recommendations. Additionally, panel members contributed 9 further GPPs based on clinical expertise. Of the 97 total recommendations, 95 received a relevance score above 7, while 2 scored between 4 and 6.9; none scored below 4.

Conclusions

This consensus effort and the resulting document represent a comprehensive evaluation of the available evidence regarding the role of medical oncologists within MOGs and DTCPs. The objective is to propose standardized criteria for the optimal management of cancer patients (pts) across all phases of care from initial diagnosis and staging to treatment, follow-up, and end-of-life support.
诊断和治疗护理路径(DTCPs)是临床治理工具,旨在通过多学科团队协调应用标准化、循证干预措施来管理特定患者群体的护理。他们的主要目标是确保公平、及时和具有成本效益地获得高质量的护理。材料和方法由意大利肿瘤医学协会(AIOM)认可的公认意见领袖小组召开会议,以制定一份共识文件,确定医学肿瘤学家在多学科肿瘤小组(mog)和dtcp中的作用。该小组采用兰德/加州大学洛杉矶分校“共识会议”形式的适当性方法,评估了一系列来自科学文献和专家生成的良好实践点(GPPs)审查的声明。这些声明涉及五个关键领域。肿瘤学家在诊断阶段的技能2。遵循整齐。缓和care4。肿瘤患者诊疗护理路径的管理医学治疗。为了进一步支持每个主题,提出了说明性案例研究。结果共有21篇文章符合纳入标准,提出88条循证建议。此外,小组成员根据临床专业知识贡献了9个进一步的gpp。在总共97条推荐中,95条相关度评分在7分以上,2条评分在4到6.9分之间;没有一个得分低于4分。这一共识努力和最终文件代表了对医学肿瘤学家在mog和dtcp中作用的现有证据的全面评估。目的是为癌症患者的最佳管理提出标准化的标准,从最初的诊断和分期到治疗、随访和临终支持的所有护理阶段。
{"title":"Defining the role and competencies of the medical oncologist in diagnostic and therapeutic care pathways: Consensus recommendations from the Italian association of medical oncology (AIOM)","authors":"Rossana Berardi ,&nbsp;Francesca Rossi ,&nbsp;Valentina Tarantino ,&nbsp;Michele De Tursi ,&nbsp;Angelo Dinota ,&nbsp;Giancarlo Di Pinto ,&nbsp;Roberto Bianco ,&nbsp;Francesco Leonardi ,&nbsp;Alessandra Bearz ,&nbsp;Alessandra Fabi ,&nbsp;Alessandro Pastorino ,&nbsp;Franco Nolè ,&nbsp;Paolo Alessandroni ,&nbsp;Francesco Carrozza ,&nbsp;Lucio Buffoni ,&nbsp;Tiziana Latiano ,&nbsp;Daniele Farci ,&nbsp;Massimiliano Spada ,&nbsp;Carmelo Bengala ,&nbsp;Stefania Kinspergher ,&nbsp;Roberto Papa","doi":"10.1016/j.jcpo.2026.100701","DOIUrl":"10.1016/j.jcpo.2026.100701","url":null,"abstract":"<div><h3>Background</h3><div>Diagnostic and Therapeutic Care Pathways (DTCPs) are clinical governance tools aimed at managing the care of specific patient populations through the coordinated application of standardized, evidence-based interventions by multidisciplinary teams. Their primary goal is to ensure equitable, timely, and cost-effective access to high-quality care.</div></div><div><h3>Materials and method</h3><div>A panel of recognized opinion leaders, endorsed by the Italian Association of Medical Oncology (AIOM), was convened to develop a consensus document defining the role of the medical oncologist within Multidisciplinary Oncology Groups (MOGs) and DTCPs. Employing the RAND/UCLA Appropriateness Method in its “consensus conference” format, the panel evaluated a series of statements derived from a review of the scientific literature and expert-generated Good Practice Points (GPPs). These statements addressed five key areas.<ul><li><span>1.</span><span><div>Skills of the Oncologist in the diagnostic phase</div></span></li></ul></div><div><ul><li><span>2.</span><span><div>Follow up</div></span></li></ul><ul><li><span>3.</span><span><div>Palliative care</div></span></li></ul></div><div><ul><li><span>4.</span><span><div>Management of the diagnostic and therapeutic care pathway of the oncological patient</div></span></li></ul><ul><li><span>5.</span><span><div>Medical therapy.</div></span></li></ul></div><div>To further support each topic, illustrative case studies were presented.</div></div><div><h3>Results</h3><div>A total of 21 articles met the inclusion criteria, yielding 88 evidence-based recommendations. Additionally, panel members contributed 9 further GPPs based on clinical expertise. Of the 97 total recommendations, 95 received a relevance score above 7, while 2 scored between 4 and 6.9; none scored below 4.</div></div><div><h3>Conclusions</h3><div>This consensus effort and the resulting document represent a comprehensive evaluation of the available evidence regarding the role of medical oncologists within MOGs and DTCPs. The objective is to propose standardized criteria for the optimal management of cancer patients (pts) across all phases of care from initial diagnosis and staging to treatment, follow-up, and end-of-life support.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"47 ","pages":"Article 100701"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inpatient mortality and failure to rescue in lung cancer patients by hospital certification status: Cross-sectional analysis of nationwide german discharge data 2014–2023 医院认证状态对肺癌患者住院死亡率和抢救失败的影响:2014-2023年德国全国出院数据的横断面分析
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-01 Epub Date: 2026-02-23 DOI: 10.1016/j.jcpo.2026.100715
Leonie Meyer , Christoph Kowalski , Martin Utzig , Philipp Hengel

Introduction

Lung cancer is the leading cause of cancer-related mortality in Germany. Certification of lung cancer centers aims to improve quality of care primarily by adhering to evidence-based guidelines and minimum case volume requirements. However, the number of procedures is also a part of nationwide requirements. This study examines the association between certification status and outcomes for lung cancer patients undergoing anatomical lung resections in Germany between 2014 and 2023 while adjusting for hospital case volume (based on lung cancer resections) and patient characteristics.

Methods

Nationwide Diagnosis-Related Groups data were linked with certification data from the German Cancer Society. Generalized logit regression models adjusted for age, sex, comorbidities, and hospital case volume were used to estimate in-hospital mortality and failure to rescue rates along with the corresponding 95 % confidence intervals. For each year, two separate analyses were conducted: one adjusting for patient characteristics only, and another additionally adjusting for hospital caseload.

Results

Adjusted analyses showed a trend of lower in-hospital mortality and failure to rescue rates in certified centers, both with and without adjustment for hospital case volume. However, statistical significance was observed only in the years 2020 and 2021, and only when case volume per hospital was not included as a covariate.

Conclusion

While certified centers demonstrated lower in-hospital mortality and failure to rescue rates in specific years, including hospital case volume as a covariate reduced the magnitude of the differences between certified and non-certified hospitals. These results suggest that certification status and hospital case volume interact in complex ways, underscoring the need for further investigation into their independent and combined effects on patient outcomes.
简介:肺癌是德国癌症相关死亡的主要原因。肺癌中心认证的目的主要是通过坚持循证指南和最低病例量要求来提高护理质量。然而,程序的数量也是全国要求的一部分。本研究考察了2014年至2023年在德国接受解剖性肺切除术的肺癌患者的认证状态与结果之间的关系,同时调整了医院病例量(基于肺癌切除术)和患者特征。方法:全国诊断相关组织的数据与德国癌症协会的认证数据相关联。使用年龄、性别、合并症和住院病例量调整的广义logit回归模型来估计住院死亡率和抢救失败率,以及相应的95% %置信区间。每年进行两项独立分析:一项仅调整患者特征,另一项额外调整医院病例量。结果:调整后的分析显示,无论是否对医院病例量进行调整,认证中心的住院死亡率和抢救失败率都有降低的趋势。然而,只有在2020年和2021年,并且每家医院的病例量不作为协变量纳入时,才观察到统计学意义。结论:虽然认证中心在特定年份表现出较低的住院死亡率和抢救失败率,但将医院病例量作为协变量减少了认证医院和非认证医院之间的差异程度。这些结果表明,认证状态和医院病例量以复杂的方式相互作用,强调需要进一步调查它们对患者预后的独立和联合影响。
{"title":"Inpatient mortality and failure to rescue in lung cancer patients by hospital certification status: Cross-sectional analysis of nationwide german discharge data 2014–2023","authors":"Leonie Meyer ,&nbsp;Christoph Kowalski ,&nbsp;Martin Utzig ,&nbsp;Philipp Hengel","doi":"10.1016/j.jcpo.2026.100715","DOIUrl":"10.1016/j.jcpo.2026.100715","url":null,"abstract":"<div><h3>Introduction</h3><div>Lung cancer is the leading cause of cancer-related mortality in Germany. Certification of lung cancer centers aims to improve quality of care primarily by adhering to evidence-based guidelines and minimum case volume requirements. However, the number of procedures is also a part of nationwide requirements. This study examines the association between certification status and outcomes for lung cancer patients undergoing anatomical lung resections in Germany between 2014 and 2023 while adjusting for hospital case volume (based on lung cancer resections) and patient characteristics.</div></div><div><h3>Methods</h3><div>Nationwide Diagnosis-Related Groups data were linked with certification data from the German Cancer Society. Generalized logit regression models adjusted for age, sex, comorbidities, and hospital case volume were used to estimate in-hospital mortality and failure to rescue rates along with the corresponding 95 % confidence intervals. For each year, two separate analyses were conducted: one adjusting for patient characteristics only, and another additionally adjusting for hospital caseload.</div></div><div><h3>Results</h3><div>Adjusted analyses showed a trend of lower in-hospital mortality and failure to rescue rates in certified centers, both with and without adjustment for hospital case volume. However, statistical significance was observed only in the years 2020 and 2021, and only when case volume per hospital was not included as a covariate.</div></div><div><h3>Conclusion</h3><div>While certified centers demonstrated lower in-hospital mortality and failure to rescue rates in specific years, including hospital case volume as a covariate reduced the magnitude of the differences between certified and non-certified hospitals. These results suggest that certification status and hospital case volume interact in complex ways, underscoring the need for further investigation into their independent and combined effects on patient outcomes.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"47 ","pages":"Article 100715"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality improvement initiatives on colposcopy and treatment of cervical pre-cancer services in Bhutan: Experiences, challenges, and way forward 质量改进举措阴道镜检查和治疗宫颈癌前服务在不丹:经验,挑战和前进的道路
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-01 Epub Date: 2025-12-04 DOI: 10.1016/j.jcpo.2025.100676
Namkha Dorji, Thinley Dorji, Yeshey Dorjey, Yangdon Yangdon
Bhutan has achieved 90–70–90 global targets by 2023, way ahead of the global targets of elimination of cervical cancer by 2030. However, cervical cancer remains the most prevalent cancer, among women in Bhutan. While all healthcare screening, diagnosis and treatment of cervical cancers are provided free of cost, sustainability in terms of financing and human resources and ensuring quality of services are the major challenges. Development of a national standard guideline is a major intervention towards improving the quality of colposcopy services and treatment of precancer in the country. In this article, we discuss the summary of the consensus-based practical guideline on colposcopy and treatment of cervical pre-cancers in Bhutan, challenges faced and potential way forward.
不丹到2023年实现了90-70-90的全球目标,远远超过了到2030年消除宫颈癌的全球目标。然而,在不丹妇女中,子宫颈癌仍然是最普遍的癌症。虽然宫颈癌的所有保健检查、诊断和治疗都是免费提供的,但在资金和人力资源方面的可持续性以及确保服务质量是主要挑战。制定国家标准指南是提高国内阴道镜检查服务质量和癌前病变治疗的一项主要干预措施。在这篇文章中,我们讨论了基于共识的实用指南总结阴道镜检查和治疗宫颈癌前病变在不丹,面临的挑战和潜在的前进道路。
{"title":"Quality improvement initiatives on colposcopy and treatment of cervical pre-cancer services in Bhutan: Experiences, challenges, and way forward","authors":"Namkha Dorji,&nbsp;Thinley Dorji,&nbsp;Yeshey Dorjey,&nbsp;Yangdon Yangdon","doi":"10.1016/j.jcpo.2025.100676","DOIUrl":"10.1016/j.jcpo.2025.100676","url":null,"abstract":"<div><div>Bhutan has achieved 90–70–90 global targets by 2023, way ahead of the global targets of elimination of cervical cancer by 2030. However, cervical cancer remains the most prevalent cancer, among women in Bhutan. While all healthcare screening, diagnosis and treatment of cervical cancers are provided free of cost, sustainability in terms of financing and human resources and ensuring quality of services are the major challenges. Development of a national standard guideline is a major intervention towards improving the quality of colposcopy services and treatment of precancer in the country. In this article, we discuss the summary of the consensus-based practical guideline on colposcopy and treatment of cervical pre-cancers in Bhutan, challenges faced and potential way forward.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"47 ","pages":"Article 100676"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145685016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnic disparities in breast cancer outcomes in Europe: Data gaps and policy recommendations 欧洲乳腺癌结局的种族差异:数据差距和政策建议
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-01 Epub Date: 2025-12-17 DOI: 10.1016/j.jcpo.2025.100691
Ariwan Saeed , Bamo Muhsin , Nyan Osman Saeed , Shwan Ali , Jalil Salih , Mohammed Khalid Mahmood , Karzan Murad , Shkar Othman Arif , Kamaran Ahmed , Sazgar Star , Hawbir Ahmed , Lana H. Baba Haji , Basak Barzngy
{"title":"Ethnic disparities in breast cancer outcomes in Europe: Data gaps and policy recommendations","authors":"Ariwan Saeed ,&nbsp;Bamo Muhsin ,&nbsp;Nyan Osman Saeed ,&nbsp;Shwan Ali ,&nbsp;Jalil Salih ,&nbsp;Mohammed Khalid Mahmood ,&nbsp;Karzan Murad ,&nbsp;Shkar Othman Arif ,&nbsp;Kamaran Ahmed ,&nbsp;Sazgar Star ,&nbsp;Hawbir Ahmed ,&nbsp;Lana H. Baba Haji ,&nbsp;Basak Barzngy","doi":"10.1016/j.jcpo.2025.100691","DOIUrl":"10.1016/j.jcpo.2025.100691","url":null,"abstract":"","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"47 ","pages":"Article 100691"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147394100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life in patients with advanced cancer: Critical evaluation of EORTC QLQ-C15-PAL and FACIT-PAL-14 in prospective studies 晚期癌症患者的生活质量:前瞻性研究中EORTC QLQ-C15-PAL和FACIT-PAL-14的关键评价
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-01 Epub Date: 2025-12-18 DOI: 10.1016/j.jcpo.2025.100692
Paula Tur , Eva Oldenburger , Andrew Bottomley , David Cella , Shing Fung Lee , Adrian W. Chan , Gustavo Nader Marta , Timothy Jacobs , Edward Chow , Henry C.Y. Wong , Agata Rembielak
{"title":"Quality of life in patients with advanced cancer: Critical evaluation of EORTC QLQ-C15-PAL and FACIT-PAL-14 in prospective studies","authors":"Paula Tur ,&nbsp;Eva Oldenburger ,&nbsp;Andrew Bottomley ,&nbsp;David Cella ,&nbsp;Shing Fung Lee ,&nbsp;Adrian W. Chan ,&nbsp;Gustavo Nader Marta ,&nbsp;Timothy Jacobs ,&nbsp;Edward Chow ,&nbsp;Henry C.Y. Wong ,&nbsp;Agata Rembielak","doi":"10.1016/j.jcpo.2025.100692","DOIUrl":"10.1016/j.jcpo.2025.100692","url":null,"abstract":"","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"47 ","pages":"Article 100692"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147394337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the development process of national cancer control plans in low- and middle-income countries 了解中低收入国家国家癌症控制计划的制定过程。
IF 2 Q3 HEALTH POLICY & SERVICES Pub Date : 2026-03-01 Epub Date: 2025-12-01 DOI: 10.1016/j.jcpo.2025.100670
Linsey Eldridge , Amina Chtourou , Kalina Duncan , Leslie Given , Sana Haider , Karin Hohman , Douglas M. Puricelli Perin , Yannick Romero , Zuzanna Tittenbrun , Mishka Kohli Cira

Background

As cancer incidence in low- and middle-income countries (LMICs) continues to rise, the development of National Cancer Control Plans (NCCP) has become an essential policy tool for guiding a comprehensive and coordinated response. The NCCP Development Research Initiative (NCCP DRIVE) is a qualitative study led by the International Cancer Control Partnership (ICCP) to understand the NCCP development process and contextual factors that may enable or impede effective NCCP development.

Methods

In-depth interviews were conducted with country-level cancer planners in nine countries (seven African, two South Asian) within the ICCP network. Transcripts were recorded, transcribed, and double-coded in Dedoose, then analyzed thematically using the Health Policy Triangle (HPT) framework.

Results

Findings highlight that NCCP development is dynamic and iterative, following six commonly reported phases: Initiation, Formulation, Negotiation, Communication, Implementation, and Monitoring/Evaluation. Common challenges reported by respondents included limited financial and human resources, competing priorities, fragmented health systems, and inadequate data. These constraints led to compressed timelines, overlapping planning activities, and gaps in costing and implementation plans. To address these challenges, respondents employed various strategies, including integrating cancer control efforts with existing health programs, engaging multisector actors, building political will, and securing technical assistance (TA) from partners. Building partnerships was pivotal, helping to set priorities, align plans with national and global agendas, and leverage resources. However, some respondents reported misaligned timelines and priorities, and coordination challenges.

Conclusion

This study contributes a policy framework-informed, implementation-focused analysis of NCCP development, offering practical insights into how countries navigate complex challenges to initiate and sustain cancer control planning. Findings underscore the need for flexible TA models and stronger data systems, and the value of integrating cancer control priorities within existing health systems. Understanding these dynamics from initiation to implementation offers practical insights for countries at various stages of development, and for partners providing technical assistance.
背景:随着低收入和中等收入国家(LMICs)癌症发病率的持续上升,国家癌症控制计划(NCCP)的制定已成为指导全面协调应对的重要政策工具。NCCP发展研究倡议(NCCP DRIVE)是由国际癌症控制伙伴关系(ICCP)领导的一项定性研究,旨在了解NCCP的发展过程以及可能促进或阻碍NCCP有效发展的背景因素。方法:对ICCP网络内9个国家(7个非洲国家,2个南亚国家)的国家级癌症规划人员进行了深入访谈。在Dedoose中记录、转录和双重编码转录本,然后使用健康政策三角(Health Policy Triangle, HPT)框架进行主题分析。结果:研究结果强调了NCCP的发展是动态的和迭代的,遵循六个通常报道的阶段:启动、制定、谈判、沟通、实施和监测/评估。答复者报告的共同挑战包括有限的财政和人力资源、相互竞争的优先事项、分散的卫生系统和不充分的数据。这些限制因素导致了时间表的压缩、计划活动的重叠以及成本和实施计划的差距。为了应对这些挑战,受访者采用了各种策略,包括将癌症控制工作与现有卫生规划结合起来,让多部门行为者参与进来,建立政治意愿,以及从合作伙伴那里获得技术援助。建立伙伴关系至关重要,有助于确定优先事项,使计划与国家和全球议程保持一致,并利用资源。然而,一些答复者报告了时间表和优先事项不一致以及协调方面的挑战。结论:本研究为非传染性疾病的发展提供了政策框架信息,以实施为重点的分析,为各国如何应对复杂的挑战,启动和维持癌症控制计划提供了实际见解。研究结果强调需要灵活的临床经验模型和更强大的数据系统,以及将癌症控制重点纳入现有卫生系统的价值。了解从启动到实施的这些动态,可以为处于不同发展阶段的国家和提供技术援助的合作伙伴提供实际的见解。
{"title":"Understanding the development process of national cancer control plans in low- and middle-income countries","authors":"Linsey Eldridge ,&nbsp;Amina Chtourou ,&nbsp;Kalina Duncan ,&nbsp;Leslie Given ,&nbsp;Sana Haider ,&nbsp;Karin Hohman ,&nbsp;Douglas M. Puricelli Perin ,&nbsp;Yannick Romero ,&nbsp;Zuzanna Tittenbrun ,&nbsp;Mishka Kohli Cira","doi":"10.1016/j.jcpo.2025.100670","DOIUrl":"10.1016/j.jcpo.2025.100670","url":null,"abstract":"<div><h3>Background</h3><div>As cancer incidence in low- and middle-income countries (LMICs) continues to rise, the development of National Cancer Control Plans (NCCP) has become an essential policy tool for guiding a comprehensive and coordinated response. The NCCP Development Research Initiative (NCCP DRIVE) is a qualitative study led by the International Cancer Control Partnership (ICCP) to understand the NCCP development process and contextual factors that may enable or impede effective NCCP development.</div></div><div><h3>Methods</h3><div>In-depth interviews were conducted with country-level cancer planners in nine countries (seven African, two South Asian) within the ICCP network. Transcripts were recorded, transcribed, and double-coded in Dedoose, then analyzed thematically using the Health Policy Triangle (HPT) framework.</div></div><div><h3>Results</h3><div>Findings highlight that NCCP development is dynamic and iterative, following six commonly reported phases: Initiation, Formulation, Negotiation, Communication, Implementation, and Monitoring/Evaluation. Common challenges reported by respondents included limited financial and human resources, competing priorities, fragmented health systems, and inadequate data. These constraints led to compressed timelines, overlapping planning activities, and gaps in costing and implementation plans. To address these challenges, respondents employed various strategies, including integrating cancer control efforts with existing health programs, engaging multisector actors, building political will, and securing technical assistance (TA) from partners. Building partnerships was pivotal, helping to set priorities, align plans with national and global agendas, and leverage resources. However, some respondents reported misaligned timelines and priorities, and coordination challenges.</div></div><div><h3>Conclusion</h3><div>This study contributes a policy framework-informed, implementation-focused analysis of NCCP development, offering practical insights into how countries navigate complex challenges to initiate and sustain cancer control planning. Findings underscore the need for flexible TA models and stronger data systems, and the value of integrating cancer control priorities within existing health systems. Understanding these dynamics from initiation to implementation offers practical insights for countries at various stages of development, and for partners providing technical assistance.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"47 ","pages":"Article 100670"},"PeriodicalIF":2.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Cancer Policy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1